H.R. 10115

Radiation Exposure Compensation Reauthorization Act of 2026

Sponsor: James C. Moylan

19 cosponsors
Follow this bill

Official summary

No official summary yet.

Text of the bill

Expand all
Sec. 7. Compensable cancers and diseases

The Radiation Exposure Compensation Act (Public Law 101–426; 42 U.S.C. 2210 note) is amended—

(1) in section 4(b), by amending paragraph (2) to read as follows:

Text this section adds to the law

(2) specified disease means leukemia (including chronic lymphocytic leukemia), provided the onset of the disease was at least 2 years after first exposure, and the following diseases, provided onset was at least 2 years after first exposure: multiple myeloma, lymphomas (other than Hodgkin’s disease), renal disease, thyroid diseases, and primary cancer of the: thyroid, male or female breast, esophagus, stomach, pharynx, small intestine, pancreas, bile ducts, gall bladder, salivary gland, urinary bladder, brain, colon, ovary, liver (except if cirrhosis or hepatitis B is indicated), bone, renal, rectal, prostate, uterine, cervical, skin, or lung.

; and

(2) in section 5A(e)(2)—

(A) by redesignating subparagraph (C) as subparagraph (E);

(B) by inserting after subparagraph (B) the following:

Text this section adds to the law

(C) Renal disease.

(D) Thyroid disease.

; and

(C) in subparagraph (E), as so redesignated—

(i) in clause (xvii), by striking or at the end;

(ii) in clause (xviii), by striking the period at the end and inserting a semicolon; and

(iii) by inserting at the end the following:

Text this section adds to the law

(xix) rectal;

(xx) prostate;

(xxi) uterine;

(xxii) cervical; or

(xxiii) skin.